0,651  0,004  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,582  0,014  5 Hydroxytryptamine release inhibitor
0,549  0,026  Aldehyde oxidase inhibitor
0,523  0,003  GABA C receptor agonist
0,536  0,019  Histamine release inhibitor
0,504  0,025  GABA C receptor rho-3 antagonist
0,488  0,013  Antidiabetic symptomatic
0,460  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,477  0,029  Ulceration
0,477  0,037  Calcium channel L-type activator
0,436  0,018  Radiosensitizer
0,436  0,045  Vasodilator, peripheral
0,428  0,037  FMO1 substrate
0,407  0,021  DNA synthesis inhibitor
0,427  0,047  Stroke treatment
0,383  0,004  Ferrochelatase inhibitor
0,426  0,054  CYP2C9 substrate
0,439  0,072  Antidiabetic
0,439  0,072  Cyclophilin D inhibitor
0,362  0,003  NAT2 substrate
0,444  0,086  Caspase 9 stimulant
0,370  0,024  Interleukin agonist
0,352  0,008  UDP-glucose 4-epimerase inhibitor
0,371  0,029  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,343  0,005  Porphobilinogen synthase inhibitor
0,361  0,025  Antineoplastic enhancer
0,337  0,005  Excitatory amino acid transporter EAAC1 inhibitor
0,351  0,028  Peroxidase inhibitor
0,333  0,012  Diabetic nephropathy treatment
0,383  0,066  CYP2C9 inhibitor
0,324  0,007  Aldehyde oxidase substrate
0,321  0,004  Alcohol oxidase inhibitor
0,352  0,036  FMO3 substrate
0,351  0,041  Cytostatic
0,358  0,050  Radioprotector
0,323  0,019  Gastrin inhibitor
0,331  0,028  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,316  0,022  MAP-kinase-activated kinase 5 inhibitor
0,371  0,079  Antipruritic, allergic
0,310  0,021  Diabetic retinopathy treatment
0,328  0,041  Myocardial infarction treatment
0,339  0,058  Calcium channel activator
0,346  0,066  Cholesterol antagonist
0,318  0,048  Insulysin inhibitor
0,318  0,049  Renal disease treatment
0,331  0,066  Apoptosis antagonist
0,268  0,008  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,302  0,044  5 Hydroxytryptamine uptake stimulant
0,346  0,088  GST A substrate
0,294  0,038  Antiparkinsonian, rigidity relieving
0,299  0,043  Ca2+/calmodulin-dependent protein kinase inhibitor
0,343  0,094  Atherosclerosis treatment
0,282  0,035  Ca2+/calmodulin-dependent kinase IV inhibitor
0,254  0,007  Triose-phosphate isomerase inhibitor
0,265  0,018  Succinate dehydrogenase inhibitor
0,360  0,114  Antiarthritic
0,265  0,023  Prostate disorders treatment
0,248  0,007  Protein kinase C gamma inhibitor
0,316  0,077  Antihypertensive
0,342  0,104  TNF expression inhibitor
0,249  0,012  GABA C receptor rho-2 antagonist
0,245  0,008  Arylamine N-Acetyltransferase substrate
0,238  0,004  Antidote, mercury
0,292  0,058  Flavin-containing monooxygenase substrate
0,233  0,005  GABA C receptor rho-1 antagonist
0,262  0,035  Pneumotoxic
0,291  0,064  UGT1A9 substrate
0,277  0,051  Cyclic AMP phosphodiesterase inhibitor
0,231  0,005  Electrolyte absorption antagonist
0,275  0,051  UGT1A6 substrate
0,280  0,058  Superoxide dismutase inhibitor
0,263  0,042  RNA-directed DNA polymerase inhibitor
0,271  0,050  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,278  0,060  Urologic disorders treatment
0,251  0,033  Lipocortins synthesis antagonist
0,246  0,029  3C-like protease (Human coronavirus) inhibitor
0,247  0,033  Antiviral (Hepatitis)
0,261  0,049  MAP kinase kinase 2 inhibitor
0,223  0,012  Adenylate kinase inhibitor
0,215  0,006  Phenylalanine 4-hydroxylase inhibitor
0,252  0,045  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,275  0,069  Aryl hydrocarbon receptor agonist
0,268  0,064  Heart failure treatment
0,212  0,009  Antiviral (Influenza B)
0,208  0,005  Biliverdin reductase inhibitor
0,298  0,095  Transcription factor NF kappa B inhibitor
0,273  0,070  GST M1-1 substrate
0,283  0,082  CTGF expression inhibitor
0,216  0,017  Antieczematic
0,223  0,024  Antianemic
0,210  0,012  Histidine decarboxylase inhibitor
0,228  0,029  Antiviral (Hepatitis C)
0,221  0,023  Aldehyde dehydrogenase inhibitor
0,218  0,021  Antirickettsial
0,208  0,011  GABA C receptor antagonist
0,208  0,014  Catalase inhibitor
0,266  0,073  Chemoprotective
0,258  0,068  Acute neurologic disorders treatment
0,240  0,051  DNA methyltransferase I inhibitor
0,214  0,026  Aldose reductase substrate
0,234  0,046  I kappa B kinase epsilon inhibitor
0,226  0,040  Age-related macular degeneration treatment
0,251  0,067  Tyrosine 3 hydroxylase inhibitor
0,201  0,018  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,289  0,106  CYP3A4 substrate
0,224  0,045  Mcl-1 antagonist
0,252  0,076  Antipyretic
0,220  0,046  Prostatic (benign) hyperplasia treatment
0,250  0,077  Vascular (periferal) disease treatment
0,181  0,010  Nav1.8 sodium channel blocker
0,255  0,085  UGT2B4 substrate
0,183  0,014  AMP-activated protein kinase stimulant
0,208  0,040  Muscular dystrophy treatment
0,301  0,134  Antibacterial
0,178  0,015  Creatine kinase inhibitor
0,294  0,131  CYP2C19 inhibitor
0,186  0,025  Antineoplastic antimetabolite
0,184  0,024  MAP3K9 inhibitor
0,236  0,076  Antiglaucomic
0,224  0,064  VCAM1 expression inhibitor
0,249  0,089  5 Hydroxytryptamine release stimulant
0,231  0,072  Antihypotensive
0,219  0,060  Abortion inducer
0,224  0,068  Fibrosis treatment
0,172  0,016  Heat shock protein 70 antagonist
0,254  0,101  Antipsoriatic
0,167  0,015  Ca2+-transporting ATPase inhibitor
0,219  0,067  DNA methylase inhibitor
0,182  0,031  Gout treatment
0,199  0,048  Acaricide
0,196  0,044  Antiischemic, cerebral
0,163  0,012  Keratolytic
0,167  0,017  Alcohol dehydrogenase inhibitor
0,162  0,015  NADH dehydrogenase inhibitor
0,214  0,067  Nitric-oxide synthase stimulant
0,166  0,020  HIV-1 integrase (Overall Integration) inhibitor
0,184  0,038  Cell wall synthesis inhibitor
0,176  0,031  Cystathionine beta-synthase inhibitor
0,209  0,064  Antimigraine
0,150  0,005  Poly(ADP-ribose) polymerase inhibitor
0,183  0,040  Hemostatic
0,191  0,048  Hair growth stimulant
0,260  0,118  Sodium/bile acid cotransporter inhibitor
0,235  0,093  Cardiotonic
0,158  0,017  DOPA decarboxylase inhibitor
0,185  0,045  Hexokinase inhibitor
0,208  0,069  Neurotrophic factor enhancer
0,199  0,063  5 Hydroxytryptamine 3E antagonist
0,141  0,006  AMPA receptor antagonist
0,138  0,005  Aconitate hydratase inhibitor
0,203  0,069  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,145  0,012  NAT1 substrate
0,190  0,058  Antimutagenic
0,233  0,102  Antineurogenic pain
0,239  0,109  Antihypoxic
0,138  0,009  Protein kinase C eta inhibitor
0,166  0,037  MAP kinase kinase 4 inhibitor
0,146  0,017  Glutamate dehydrogenase inhibitor
0,138  0,010  NMDA receptor agonist
0,159  0,031  Xanthine oxidase inhibitor
0,161  0,033  Aminopeptidase B inhibitor
0,199  0,072  UGT1A1 substrate
0,148  0,022  Antifungal (Pneumocystis)
0,199  0,075  Death-associated protein kinase 3 inhibitor
0,222  0,100  Proliferative diseases treatment
0,144  0,025  Uric acid excretion stimulant
0,209  0,090  Teratogen
0,173  0,054  Antiparkinsonian, tremor relieving
0,212  0,093  Antiviral (West Nile virus)
0,132  0,014  Argininosuccinate synthase inhibitor
0,214  0,096  Cardiovascular analeptic
0,172  0,055  Antidote
0,144  0,028  Beta glucuronidase inhibitor
0,132  0,017  Glutamate decarboxylase inhibitor
0,251  0,139  Antineoplastic (small cell lung cancer)
0,132  0,021  MAP-kinase-activated kinase inhibitor
0,179  0,068  UGT1A4 substrate
0,118  0,007  Antiviral (Parainfluenza)
0,147  0,037  5 Hydroxytryptamine 3A agonist
0,169  0,059  UGT2B9 substrate
0,140  0,030  Protein kinase C mu inhibitor
0,143  0,034  CC chemokine 6 receptor antagonist
0,111  0,004  Antiviral (Hepatitis D)
0,238  0,133  Interleukin 2 agonist
0,164  0,058  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,189  0,086  Histone acetyltransferase inhibitor
0,215  0,112  Immunostimulant
0,108  0,005  Nicotinic acid receptor 2 agonist
0,158  0,056  MAP kinase 3 inhibitor
0,113  0,011  NMDA receptor glycine site agonist
0,166  0,065  Neuropathy treatment
0,151  0,051  Glutamate receptor antagonist
0,128  0,029  Antispirochetal
0,137  0,039  Protein kinase (CK2) inhibitor
0,115  0,016  D-Ala-D-Ala ligase inhibitor
0,109  0,011  GABA B receptor agonist
0,129  0,032  NMDA receptor antagonist
0,114  0,017  CDC7 inhibitor
0,215  0,119  Antidiabetic (type 2)
0,101  0,005  AICAR transformylase inhibitor
0,137  0,040  Choleretic
0,101  0,005  Nicotinic acid receptor agonist
0,135  0,040  Caspase 3 inhibitor
0,160  0,066  Phospholipase A2 inhibitor
0,115  0,022  MAP-kinase-activated kinase 2 inhibitor
0,118  0,025  Rho-associated kinase II inhibitor
0,159  0,067  Interferon gamma antagonist
0,172  0,081  Antipruritic, non-allergic
0,118  0,026  Phosphofructokinase-1 inhibitor
0,129  0,039  Antineoplastic, alkylator
0,104  0,014  CDC25B inhibitor
0,119  0,030  Histamine N-methyltransferase inhibitor
0,135  0,046  Antiprotozoal (Babesia)
0,162  0,074  UGT1A3 substrate
0,101  0,013  Protein kinase C beta inhibitor
0,094  0,007  Poly(ADP-ribose) polymerase 1 inhibitor
0,132  0,046  Falcipain 3 inhibitor
0,158  0,071  Diuretic
0,142  0,055  Antihelmintic (Trematoda)
0,092  0,006  Glutamate (mGluR4) antagonist
0,136  0,051  Protein kinase (CK2) alpha inhibitor
0,187  0,101  Angiogenesis stimulant
0,180  0,095  Insulin sensitizer
0,200  0,115  DNA damaging
0,151  0,066  Glycogen synthase kinase-3 alpha inhibitor
0,160  0,075  Urinary incontinence treatment
0,172  0,087  Sedative
0,134  0,050  Sphingosine 1-phosphate receptor 4 antagonist
0,166  0,082  Phobic disorders treatment
0,243  0,160  Antineoplastic (endocrine cancer)
0,161  0,078  Neurotensin receptor agonist
0,127  0,044  Antischistosomal
0,126  0,043  Carbonic anhydrase XV inhibitor
0,213  0,131  CYP2D6 substrate
0,148  0,066  Mannose-6-phosphate isomerase inhibitor
0,102  0,021  Protein kinase C alpha inhibitor
0,106  0,026  Check point kinase 1 inhibitor
0,091  0,011  MDM2 inhibitor
0,097  0,018  Antidote, organophosphates
0,110  0,031  Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor
0,085  0,007  Glutamate (mGluR group III) antagonist
0,179  0,101  Embryotoxic
0,147  0,068  Adenylate cyclase stimulant
0,086  0,007  Dihydroorotase inhibitor
0,137  0,059  Antihyperlipoproteinemic
0,159  0,081  UGT2B7 substrate
0,109  0,031  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,146  0,068  Sphingosine 1-phosphate receptor 5 antagonist
0,092  0,014  Glutamate (mGluR6) antagonist
0,149  0,072  Movement disorders treatment
0,083  0,006  HCV NS5B polymerase inhibitor
0,177  0,101  Antihypertriglyceridemic
0,104  0,029  Glycine receptor antagonist
0,118  0,042  GST T1-1 substrate
0,102  0,027  Aminopeptidase I inhibitor
0,147  0,071  Protein kinase C nu inhibitor
0,105  0,031  Somatostatin 1 agonist
0,091  0,017  Glutamate (mGluR7) antagonist
0,090  0,015  Protein kinase C epsilon inhibitor
0,121  0,047  UGT2B1 substrate
0,170  0,096  Antiviral (Influenza)
0,134  0,060  Cathepsin H inhibitor
0,203  0,130  CYP1A2 inhibitor
0,091  0,018  Acyl-CoA dehydrogenase inhibitor
0,152  0,080  Carcinogenic, group 1
0,115  0,043  Folate antagonist
0,147  0,076  Antiviral (Influenza A)
0,158  0,086  UGT2B10 substrate
0,255  0,184  MAP kinase kinase 6 inhibitor
0,212  0,142  Hepatic disorders treatment
0,113  0,043  Antifungal (Aspergillus)
0,080  0,010  Kainate receptor antagonist
0,112  0,042  Protein kinase C delta inhibitor
0,097  0,029  GABA aminotransferase inhibitor
0,147  0,079  Raynaud's phenomenon treatment
0,084  0,016  Antihemophilic
0,076  0,007  Kainate receptor 2 antagonist
0,103  0,035  Glutamate receptor agonist
0,099  0,032  NMDA 2 receptor antagonist
0,076  0,009  Thymidylate synthase inhibitor
0,169  0,102  Focal adhesion kinase 2 inhibitor
0,089  0,023  Prostaglandin EP2 antagonist
0,182  0,117  Antihypercholesterolemic
0,157  0,091  LIM domain kinase 1 inhibitor
0,072  0,006  Poly(ADP-ribose) polymerase 2 inhibitor
0,106  0,041  Paget's disease treatment
0,147  0,082  CF transmembrane conductance regulator agonist
0,164  0,099  UDP-glucuronosyltransferase substrate
0,141  0,078  Genotoxic
0,159  0,096  Sensitization
0,084  0,021  SULT2A1 substrate
0,101  0,038  Carbonic anhydrase VI inhibitor
0,075  0,012  Ryanodine receptor antagonist
0,106  0,044  Protein kinase C zeta inhibitor
0,111  0,049  Antifibrinolytic
0,129  0,067  Antismoking
0,196  0,135  Respiratory analeptic
0,139  0,078  UGT2B15 substrate
0,067  0,006  Nerve growth factor antagonist
0,216  0,155  Multiple sclerosis treatment
0,125  0,065  Antiviral (Hepatitis B)
0,064  0,005  Uridine phosphorylase inhibitor
0,098  0,038  Granulocyte macrophage colony stimulating factor agonist
0,111  0,051  Carbonic anhydrase III inhibitor
0,088  0,029  Glycine receptor agonist
0,067  0,008  RNA-directed RNA polymerase inhibitor
0,217  0,158  Antithrombotic
0,073  0,015  Dihydroorotate oxidase inhibitor
0,072  0,014  Adenine nucleotide translocase inhibitor
0,125  0,067  Antiviral (Papilloma)
0,101  0,044  Ornithine decarboxylase inhibitor
0,106  0,049  Prolactin inhibitor
0,137  0,081  Antifungal (Cryptococcus)
0,112  0,056  Mediator release inhibitor
0,079  0,025  Xanthine dehydrogenase inhibitor
0,204  0,149  CYP1A2 substrate
0,130  0,076  Antifungal enhancer
0,105  0,051  MAP kinase kinase 1 inhibitor
0,076  0,022  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,234  0,183  Rheumatoid arthritis treatment
0,057  0,006  NMDA 2D receptor antagonist
0,090  0,039  Rho-associated kinase inhibitor
0,100  0,049  Bile acid receptor antagonist
0,054  0,004  Nicotinic acid receptor 2 antagonist
0,161  0,110  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,058  0,008  Integrin alpha2 antagonist
0,069  0,020  Myc inhibitor
0,057  0,008  Kainate receptor agonist
0,060  0,011  TRPM8 blocker
0,144  0,095  Arachidonic acid antagonist
0,063  0,015  Nicotinic acid receptor 1 agonist
0,076  0,028  Antidote, heavy metal
0,161  0,113  CYP2B6 inhibitor
0,119  0,071  Carcinogenic, group 3
0,190  0,143  CYP2C19 substrate
0,064  0,017  Heparanase inhibitor
0,092  0,046  Myeloperoxidase inhibitor
0,113  0,067  Photosensitizer
0,071  0,025  Ornithine carbamoyltransferase inhibitor
0,056  0,010  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,079  0,033  Anticholelithogenic
0,120  0,074  Coagulant
0,050  0,006  Protein kinase C beta II inhibitor
0,112  0,067  Aldehyde dehydrogenase substrate
0,055  0,011  Retinoic acid alpha receptor agonist
0,056  0,011  Fumarate hydratase inhibitor
0,154  0,110  Anesthetic general
0,055  0,012  Angiotensin AT1 receptor antagonist
0,061  0,017  Factor III inhibitor
0,098  0,055  Phosphodiesterase 6D inhibitor
0,116  0,074  Growth stimulant
0,073  0,030  NMDA 2C receptor antagonist
0,087  0,045  NAD(P)H dehydrogenase (quinone) inhibitor
0,072  0,030  Purinergic P2X1 antagonist
0,049  0,008  Protein kinase (CK2) beta inhibitor
0,070  0,029  Cyclin D1 inhibitor
0,104  0,063  Antiviral (Poxvirus)
0,052  0,011  Glutamate (mGluR3) antagonist
0,121  0,080  Papain-like protease (SARS coronavirus) inhibitor
0,121  0,081  Amylase inhibitor
0,184  0,144  Analeptic
0,163  0,123  Antineoplastic (glioma)
0,045  0,005  Protein kinase C beta I inhibitor
0,177  0,138  Calpain inhibitor
0,148  0,109  Phospholipase C inhibitor
0,072  0,033  Carbamoyl phosphate synthetase inhibitor
0,167  0,129  NOS2 expression inhibitor
0,052  0,014  Retinoid X alpha receptor agonist
0,060  0,023  Lysophosphatidic acid 3 receptor antagonist
0,104  0,067  Antiprotozoal (Toxoplasma)
0,063  0,027  NMDA 2A receptor antagonist
0,085  0,049  Xanthine oxidase substrate
0,092  0,056  Actinic keratosis treatment
0,104  0,069  Antihelmintic (Fasciola)
0,058  0,022  Adenosine deaminase inhibitor
0,118  0,082  Retinoprotector
0,080  0,045  MAP kinase kinase 7 inhibitor
0,062  0,027  Prostaglandin E2 antagonist
0,062  0,027  Dihydroorotate dehydrogenase inhibitor
0,060  0,026  Nicotinic alpha3beta2 receptor antagonist
0,047  0,013  Glutamate (mGluR8) agonist
0,052  0,018  GABA B receptor antagonist
0,045  0,012  Free fatty acid receptor 1 antagonist
0,052  0,019  Glutamate (mGluR1a) antagonist
0,113  0,081  MAP kinase kinase inhibitor
0,148  0,116  Pyruvate kinase inhibitor
0,038  0,007  Integrin alpha2beta1 antagonist
0,138  0,108  Dual specificity phosphatase inhibitor
0,067  0,036  Prostaglandin F2 alpha antagonist
0,048  0,017  GABA uptake inhibitor
0,114  0,084  Toll-Like receptor 2 antagonist
0,042  0,012  Angiotensin II receptor antagonist
0,049  0,019  Factor XIa inhibitor
0,092  0,063  Antithrombocytopenic
0,047  0,019  Retinoid X receptor agonist
0,058  0,030  Thromboxane synthase inhibitor
0,086  0,058  Antileprosy
0,110  0,082  Antiseptic
0,058  0,030  Immunoglobulin Fc receptor antagonist
0,142  0,115  ATPase inhibitor
0,045  0,018  Farnesoid X receptor agonist
0,031  0,004  Vesicular glutamate transport inhibitor
0,061  0,034  Carbonic anhydrase VB inhibitor
0,041  0,014  AMPA 1 receptor antagonist
0,112  0,086  M17 leucyl aminopeptidase inhibitor
0,073  0,047  Phospholipase D inhibitor
0,118  0,091  Liver cirrhosis treatment
0,035  0,009  Kainate receptor 1 antagonist
0,116  0,091  Alkaline phosphatase inhibitor
0,035  0,010  NMDA receptor glycine site antagonist
0,041  0,016  Glutamate (mGluR8) antagonist
0,034  0,009  Antibiotic Naphthyridine-like
0,127  0,102  Thiol protease inhibitor
0,111  0,087  Contraceptive female
0,037  0,014  Hypoxanthine phosphoribosyltransferase inhibitor
0,112  0,089  DNA repair enzyme inhibitor
0,061  0,038  Glutamate (mGluR1) antagonist
0,039  0,017  Tryptophan 5 hydroxylase inhibitor
0,072  0,050  Janus tyrosine kinase 3 inhibitor
0,043  0,021  AMPA 4 receptor antagonist
0,092  0,071  Antiemetic
0,032  0,010  Thymidine phosphorylase inhibitor
0,044  0,022  Dihydropteroate synthase inhibitor
0,123  0,102  SULT1A3 substrate
0,071  0,051  Peroxisome proliferator-activated receptor gamma antagonist
0,121  0,101  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,038  0,019  Somatostatin 5 antagonist
0,197  0,178  ICAM1 expression inhibitor
0,093  0,075  Urease inhibitor
0,125  0,106  Eye irritation, high
0,143  0,125  Non-steroidal antiinflammatory agent
0,072  0,054  S-adenosyl-L-methionine decarboxylase inhibitor
0,098  0,080  Mucolytic
0,073  0,055  Carbonic anhydrase XIII inhibitor
0,069  0,052  Benzodiazepine agonist
0,034  0,017  AMPA 3 receptor antagonist
0,041  0,025  Membrane dipeptidase inhibitor
0,188  0,171  AR expression inhibitor
0,055  0,039  Bombesin 3 receptor antagonist
0,052  0,037  Autotaxin inhibitor
0,057  0,041  CDK4/cyclin D1 inhibitor
0,024  0,009  Antibiotic Quinolone-like
0,022  0,007  Nicotinic acid receptor 1 antagonist
0,146  0,131  Osteoarthritis treatment
0,185  0,171  MAP kinase kinase 3 inhibitor
0,142  0,127  Catenin beta inhibitor
0,059  0,045  Neuraminidase inhibitor
0,119  0,105  Corneal wound healing stimulator
0,056  0,042  Pregnane X receptor antagonist
0,047  0,033  Glutamate (mGluR group I) agonist
0,040  0,026  Urate transporter 1 inhibitor
0,025  0,012  Bombesin agonist
0,035  0,022  Carnitine palmitoyltransferase inhibitor
0,141  0,128  Death-associated protein kinase 2 inhibitor
0,095  0,082  Factor V inhibitor
0,053  0,040  DNA helicase inhibitor
0,035  0,022  Carnitine palmitoyltransferase 1 inhibitor
0,026  0,014  Glutamate (mGluR1) agonist
0,066  0,054  Prostaglandin-E synthase inhibitor
0,022  0,010  Retinoic acid beta receptor agonist
0,033  0,021  Glutamate (mGluR3) agonist
0,034  0,022  Sodium-dependent vitamin C transporter 2 inhibitor
0,104  0,092  Mental retardation treatment
0,069  0,057  Antibiotic
0,015  0,003  Folate transporter 1 inhibitor
0,044  0,034  Neuraminidase (Influenza A) inhibitor
0,060  0,049  DNA gyrase inhibitor
0,018  0,007  Egl nine homolog 1 inhibitor
0,094  0,084  GABA receptor agonist
0,023  0,013  Retinoic acid gamma receptor agonist
0,027  0,016  Methionyl aminopeptidase 2 inhibitor
0,021  0,011  Bombesin 3 receptor agonist
0,048  0,038  Diacylglycerol O-acyltransferase inhibitor
0,047  0,037  Plasminogen activator inhibitor antagonist
0,047  0,037  Topoisomerase II beta inhibitor
0,015  0,005  Egl nine homolog 3 inhibitor
0,117  0,108  Chemopreventive
0,030  0,021  Purinergic P2Y14 antagonist
0,023  0,014  GRP78 expression inhibitor
0,016  0,008  Angiotensin AT1B receptor antagonist
0,089  0,080  Anabolic
0,063  0,055  Carbonic anhydrase VA inhibitor
0,262  0,254  Antiinflammatory
0,088  0,080  Sulfotransferase substrate
0,074  0,066  Protein kinase A inhibitor
0,064  0,057  HIV-1 integrase inhibitor
0,118  0,111  Acetylcholine M1 receptor antagonist
0,045  0,038  Glucose-6-phosphate isomerase inhibitor
0,137  0,131  Cyclin-dependent kinase 3 inhibitor
0,047  0,041  CD45 antagonist
0,101  0,095  Interleukin 8 antagonist
0,040  0,034  Glutamate (mGluR group III) agonist
0,020  0,014  Retinoic acid alpha receptor antagonist
0,038  0,033  Thymidine kinase inhibitor
0,046  0,041  Bombesin 2 receptor antagonist
0,083  0,077  Polo-like kinase-1 inhibitor
0,135  0,130  Psychostimulant
0,031  0,027  Purinergic P2Y2 antagonist
0,022  0,018  Retinoid X gamma receptor agonist
0,021  0,017  Glutamate (mGluR1a) agonist
0,022  0,018  Retinoic acid receptor agonist
0,020  0,016  Neuraminidase (Influenza B) inhibitor
0,045  0,042  Antiviral (Herpesvirus 3, Human)
0,035  0,032  Retinoid X receptor antagonist
0,208  0,205  15-Lipoxygenase inhibitor
0,141  0,138  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,039  0,036  NMDA receptor subunit 3B antagonist
0,174  0,172  Neuropeptide Y2 antagonist
0,032  0,029  Retinoid X alpha receptor antagonist
0,017  0,015  Retinoic acid receptor antagonist
0,017  0,015  Methylmalonyl-CoA mutase inhibitor
0,031  0,029  Glutamate (mGluR4) agonist
0,107  0,106  Gastritis treatment
0,019  0,018  Retinoid X beta receptor agonist
0,040  0,039  Mannosidase inhibitor
0,061  0,059  Syk tyrosine kinase inhibitor
0,035  0,034  MAP3K5 inhibitor
0,038  0,037  Guanylate cyclase inhibitor
0,041  0,041  Glutamate (mGluR5) agonist
0,019  0,019  GABA transporter inhibitor
0,092  0,092  Adenylate cyclase inhibitor

